BioNeutral Confirms Broad Spectrum Efficacy with Its Ygiene AntimicrobialYgiene(TM) Antimicrobial Has Been Found to Eradicate Clostridium Difficile (C. diff.) Spores in Seconds
NEWARK, N.J., July 22, 2008 /PRNewswire/ -- BioNeutral announces successful independent laboratory test results which showed that Ygiene(TM) completely eliminates C. diff. spores in seconds. C. diff. represents a very serious health threat to people recovering from surgery or other serious illnesses in hospitals, convalescent homes, for the elderly and for health care providers. Ygiene's(TM) ability to eliminate C. diff. spores in seconds means that health care facilities can quickly be disinfected and made safe, thereby saving thousands of lives a year.
Dr. Philip Tierno, Director of Clinical Microbiology and Diagnostic Immunology at Langone Medical Center, , has previously tested Ygiene(TM) against a broad spectrum of microorganisms and is very familiar with its attributes. Dr. Tierno describes Ygiene(TM) 301 as follows:
"There is nothing better. (Virtually nothing compares with it) There is nothing that works faster. (Kills in seconds) There is nothing that has a more complete kill. (Kills 100% of organisms) There is nothing wider in spectrum. (Kills any and all microbes)
There is nothing that leaves the environment more green. (It eventually breaks down into innocuous substances.)"
Dr. Andy Kielbania, Chief Scientist at BioNeutral, stated that "We are extremely pleased with these independent laboratory results which show that Ygiene(TM) can significantly reduce the health risks associated with harmful microorganisms for all people in the health care arena. These results along with previous test results affirm the potent broad spectrum efficacy of our Ygiene(TM) antimicrobial."
About BioNeutral Laboratories Corporation
BioNeutral was organized in 2003 to commercialize a novel combinational chemistry-based technology that can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses and spores. The formulations are "Green" and include natural and common ingredients which are found in baby products and the foods we eat. These widely used compounds are combined in unique ways to create enhanced results.
BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications. The products include BioNeutralizers and ChemoNeutralizers. BioNeutralizers disinfect, decontaminate and sterilize. BioNeutral believes it has the broadest-based, fastest acting, most effective and safest antimicrobial known. This class of products has important applications for consumers, healthcare and the military. ChemoNeutralizers irreversibly bind chemical contaminant and toxin molecules and render them harmless. Product applications include industrial pollution and protection against chemical weapons of mass destruction.
About Dr. Philip Tierno
Dr. Tierno is a consultant to BioNeutral. He is the Director of Clinical Microbiology and Diagnostic Immunology at Langone Medical Center, . He is also an Associate Professor at the School of Medicine, NYU College of Dentistry and SUNY School of Optometry in New York City. Dr. Tierno is a member of the NYC Mayor's MRC (Medical Reserve Corps) and a former member of New York City's task force on bioterrorism. Dr. Tierno's work in the field of microbiology has resulted in numerous articles and texts that have been published in medical and scientific journals. He is co-editor and author of several books on microbes and biological protection.
Contact: Info@bioneutralgroup.com Dr. Andy Kielbania Chief Scientist firstname.lastname@example.org Dr. Philip Tierno Consultant email@example.com
This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.
CONTACT: Dr. Andy Kielbania, Chief Scientist of BioNeutral LaboratoriesCorporation, ; or Dr. Philip Tierno, Consultant forBioNeutral Laboratories Corporation, firstname.lastname@example.org email@example.com
Terms and conditions of use apply
Copyright © 2008 PR Newswire Association LLC. All rights reserved.
A United Business Media Company
Posted: July 2008